Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Association of RAS Mutation Location and Oncologic Outcomes After Resection of Colorectal Liver Metastases.

Annals of surgical oncology - 1 Feb 2021

Saadat Lily V, Boerner Thomas, Goldman Debra A, Gonen Mithat, Frankel Timothy L, Vakiani Efsevia, Kingham T Peter, Jarnagin William R, Wei Alice C, Soares Kevin C, Solit David B, D'Angelica Michael I

Abstract excerpt

BACKGROUND: RAS mutations are prognostic for patients with metastatic colorectal cancer (mCRC). We investigated clinical, pathologic, and survival differences based on RAS exon for patients with colorectal liver metastases (CRLM). METHODS: This retrospective, single-center study included patients with R0/R1 resection of CRLM from 1992 to 2016. Patients with unresected extrahepatic disease or liver-first resection...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Colorectal Neoplasms
Share to Liver Neoplasms

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Mutation

Share to Prognosis

Share to Proto-Oncogene Proteins p21(ras)

Source

Open in PubMed Open full text

Identifiers

PMID: 32683635
DOI: 10.1245/s10434-020-08862-3
PMCID: PMC7854850

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Association of RAS Mutation Location and Oncologic Outcomes After Resection of Colorectal Liver Metastases.PMID 32683635Read ↗

Prognostic value of the combination of primary tumor location and RAS mutational status on patients with colorectal liver metastasis undergoing hepatectomy.Semantic proximity Read ↗

Mutation location on the RAS oncogene affects pathologic features and survival after resection of colorectal liver metastases.Semantic proximity Read ↗

Mutation Status of RAS, TP53 , and SMAD4 is Superior to Mutation Status of RAS Alone for Predicting Prognosis after Resection of Colorectal Liver MetastasesSemantic proximity Read ↗

Anatomic Resection Is Not Required for Colorectal Liver Metastases with RAS Mutation.Semantic proximity Read ↗

Clinical significance and prognostic relevance of KRAS, BRAF, PI3K and TP53 genetic mutation analysis for resectable and unresectable colorectal liver metastases: A systematic review of the current evidence.Semantic proximity Read ↗

Prognostic Value of KRAS Exon-specific Mutations in Patients With Colorectal Cancer.Semantic proximity Read ↗

Reevaluating the prognostic value of RAS mutation status in patients with resected liver metastases from colorectal cancer: A systematic review and meta-analysis.Semantic proximity Read ↗

From bench to bedside: Clinical implications of KRAS status in patients with colorectal liver metastasis.Semantic proximity Read ↗

Prognosis of Synchronous Colorectal Liver Metastases After Simultaneous Curative-Intent Surgery According to Primary Tumor Location and KRAS Mutational Status.Semantic proximity Read ↗

Clinical Features and Outcomes of Patients with Colorectal Cancers Harboring NRAS Mutations.Semantic proximity Read ↗

Clinical and prognostic implications of RAS mutations in metastatic colorectal cancer.Semantic proximity Read ↗

Prognostic value of KRAS exon 2, exon 3 and exon 4 mutations in colorectal cancer patientsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.